Product information and disease descriptionPlace of product in therapyDisease description
Clinical presentation - signs and symptoms
5 evidence topics · 9 sources
Cognitive symptoms: excessive, uncontrollable worry
Psychological symptoms: restlessness, irritability, and difficulty concentrating
Somatic symptoms: muscle tension, fatigue, and autonomic complaints
“Being easily fatigued.” (opens the source at this quote in a new tab)
“Muscle tension.” (opens the source at this quote in a new tab)
Sleep symptoms: difficulty falling or staying asleep, or restless sleep
Functional impairment: social, occupational, and role functioning
“Respondents with 12-month GAD reported a mean (SE) of 41.2 days (2.4) out of role due to GAD in the past year. Half (50.6%) of the 12-month cases reported severe functional impairment resulting from GAD” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The rate of severe impairment was lower yet still substantial (35.3%) among individuals with GAD who had no comorbid disorders” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Respondents rated the extent of interference with home management, work, close relationships, and social life on separate 0-to-10 scales.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Disability and impairment in pure GAD were equivalent to pure mood disorders, but significantly greater than in pure substance use, and other anxiety and personality disorders.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
| Generalized anxiety disorder, 12-month cases (NCS-R) | Quoted value, % (se) |
|---|---|
| Twelve-month prevalence | “3.1 (0.2)”View highlighted excerpt for this quote |
| Serious | “32.3 (2.9)”View highlighted excerpt for this quote |
| Moderate | “44.6 (4.0)”View highlighted excerpt for this quote |
| Mild | “23.1 (2.9)”View highlighted excerpt for this quote |